These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19843116)

  • 21. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
    Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
    Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
    Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
    Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
    Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
    Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Randomized population study of screening for intestinal cancer with Hemoccult-II].
    Kronborg O; Fenger C; Olsen J; Jørgensen OD; Søndergaard O
    Ugeskr Laeger; 1997 Aug; 159(33):4977-81. PubMed ID: 9281212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved survival in young women with colorectal cancer.
    Koo JH; Jalaludin B; Wong SK; Kneebone A; Connor SJ; Leong RW
    Am J Gastroenterol; 2008 Jun; 103(6):1488-95. PubMed ID: 18510616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
    Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
    Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening practices of patients presenting for resection of a colorectal neoplasm.
    Hedrick TL; Galloway RP; McElearney ST; Smith RL; Ledesma EJ; Wilson WH; Sawyer RG; Friel CM; Foley EF
    Am Surg; 2006 Jan; 72(1):89-95. PubMed ID: 16494194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of a study on populational colorectal cancer screening].
    Courtier R; Casamitjana M; Macià F; Panadés A; Castells X; Gil MJ; Parés D; Sánchez-Ortega JM; Grande L
    Cir Esp; 2009 Mar; 85(3):152-7. PubMed ID: 19309603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bowel cancer screening in England: a qualitative study of GPs' attitudes and information needs.
    Woodrow C; Rozmovits L; Hewitson P; Rose P; Austoker J; Watson E
    BMC Fam Pract; 2006 Sep; 7():53. PubMed ID: 16981989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bowel cancer screening--a role for general practice.
    Foreman L
    Aust Fam Physician; 2009 Apr; 38(4):200-3. PubMed ID: 19350068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Colorectal cancer screening: advice from the Health Council of the Netherlands].
    van Veen W; Mali WP
    Ned Tijdschr Geneeskd; 2009; 153():A1441. PubMed ID: 20003552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and survival rate of elderly patients with colorectal cancer detected by immunochemical occult blood screening.
    Zhang B; Fattah A; Nakama H
    Hepatogastroenterology; 2000; 47(32):414-8. PubMed ID: 10791202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
    Tong S; Hughes K; Oldenburg B; Del Mar C
    Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival benefit of increasing colorectal cancer screening uptake in Wolverhampton, UK: an exploratory study.
    Anand V; Gwinnett J; Phillips A
    Public Health; 2012 Sep; 126 Suppl 1():S44-S46. PubMed ID: 22769598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of colorectal cancer stage among HMO members targeted for screening.
    Myers RE; Murray J; Weinberg D; McGrory G; Wolf T; Caveny J; Hanchak N; Schlackman N; Comis R
    Arch Intern Med; 1997 Sep; 157(17):2001-6. PubMed ID: 9308512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends.
    McClements PL; Madurasinghe V; Thomson CS; Fraser CG; Carey FA; Steele RJ; Lawrence G; Brewster DH
    Cancer Epidemiol; 2012 Aug; 36(4):e232-42. PubMed ID: 22425027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.